Prelude Capital Management’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Prelude Capital Management’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-103,600	Closed	-$1.01M	–	2202
2022 Q1	$1.01M	Hold	103,600	–	–	0.03%	575
2021 Q4	$1.01M	Hold	103,600	–	–	0.03%	604
2021 Q3	$1.01M	Buy	103,600 +51,700	+100%	+$498K	0.03%	571
2021 Q2	$501K	Buy	+51,900	New	+$507K	0.01%	945

Other funds holding MSAC

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Prelude Capital Management's MSAC Position: Q2 2022 in Review

Prelude Capital Management sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q2 2022, closing a stake of 103,600 shares — an estimated $1.01M sold.

Prelude Capital Management first reported a position in MSAC in Q2 2021 and held it in 4 quarters. The position peaked at $1.01M in Q1 2022. 54 funds tracked by Wall St. Rank hold MSAC as of Q2 2022.

Prelude Capital Management reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q2 2022 after selling out during the quarter.
Prelude Capital Management sold 103,600 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q2 2022, an estimated $1.01M.
Prelude Capital Management first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 4 quarters.
Prelude Capital Management's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $1.01M in Q1 2022.
54 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q2 2022.

Based on Prelude Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.